Feedback / Questions
emavusertib (CA-4948) - Curis, Dr. Reddy’s
Keytruda (pembrolizumab) - Merck (MSD)
https://www.prnewswire.com/news-releases/curis-enters-into-agreement-for-emavusertib--pembrolizumab-combination-study-in-melanoma-302005577.html
Dec 5, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next